Compression Therapy Market Size, Share, Growth Analysis, By Product(Compression Bandages, Compression Wraps, Compression Stockings [Class I Compression Stockings, Class II Compression Stockings), By Application(Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Leg Ulcer Treatment), By Distribution Channel(Pharmacies & Retailers, E-commerce Platforms, Hospitals & Clinics, Home Care Settings), By Region - Industry Forecast 2024-2031

Global Compression Therapy Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.11 billion in 2023 to USD 6.26 billion by 2031, growing at a CAGR of 5.40% during the forecast period (2024-2031).

The main competitors in the compression therapy market are concentrating their efforts on expanding their worldwide and regional customer bases through acquisitions, mergers, and expansions. Companies in the compression therapy market use acquisition, regulatory clearances, and the introduction of new products as their main strategies. Key businesses are focusing their efforts on the creation of advanced and affordable products as well as on distribution deals to broaden their market reach, notably in Asia Pacific. In our Compression Therapy market reports, some of the leading Compression Therapy players are as follows: medi GmbH & Co. KG (Germany), Medtronic plc (Ireland), SIGVARIS GROUP. (US), Juzo (Germany), PAUL HARTMANN AG (Germany), 3M (US), Spectrum Healthcare. (India), BIOCOMPRESSION SYSTEMS (US), Gottfried Medical, Inc. (US), BSN medical (Germany), Arjo. (Sweden), DJO, LLC (US), Tactile Medical (US), SANYLEG SRL a socio unico (Italy), Cardinal Health. (US), Devon Medical Products (US), THUASNE SAS (US), ACI Medical, LLC (US), Ofa Bamberg GmbH (Germany), Mego Afek A.C. ltd. (Israel), Medline Industries, Inc. (US) '3M (US) ', 'ArjoHuntleigh (Sweden) ', 'Bio Compression Systems, Inc. (US) ', 'Cardinal Health, Inc. (US) ', 'ConvaTec Inc. (UK) ', 'Julius Zorn GmbH (Germany) ', 'Medi GmbH & Co. KG (Germany) ', 'Paul Hartmann AG (Germany) ', 'Sanyleg S.r.l. (Italy) ', 'Sigvaris Group (Switzerland) ', 'Smith & Nephew PLC (UK) ', 'Tactile Medical Systems Technology, Inc. ("Tactile Medical") (US) ', 'Mego Afek Ltd. (Israel) ', 'Medline Industries, LP (US) ', 'Gottfried Medical, Inc. (US) ', 'ThermoTek, Inc. (US) ', 'Bauerfeind AG (Germany) ', 'OFA Bamberg GmbH (Germany) ', 'ACI Medical, LLC (US) ', 'Airos Medical Inc. (US) ', 'Barcelcom Têxteis, S.A. (Portugal) ', 'Cizeta Medicali S.p.A. (Italy) ', 'Bosl Medizintechnik (Germany)'

There have been rapid technological advancements in the field of wound care, as well as an increase in the number of clinics offering prevention and rehabilitation services.

For patients with cystic fibrosis (CF), the most recent high frequency chest compression (HFCC) technology is used to remove mucus discharges from airways and enhance lung function. The system comprises of a variable air pulse delivery system and a non-stretch inflatable vest worn by the patient to cover the chest bandages. The bandages are applied at full stretch and feature printed ovals or rectangles for improved bandage extension.

North America is anticipated to hold the greatest market share for compression therapy in 2021. This is mostly due to the increase in orthopaedic and spinal operations, the rise in lymphedema, varicose veins, and DVT cases, the frequency of sports injuries, and the existence of several compression therapy product producers in the area.